BeatO raises $33 million in Series B funding round
- ByStartupStory | November 16, 2022
BeatO, a complete virtual care platform for controlling and reversing Diabetes, based via way of means of Gautam Chopra, Yash Sehgal and Kunal Kinalekar, has raises $33 million in Series B investment led via way of means of Lightrock India with participation from HealthQuad, Flipkart Ventures and present traders.
Commenting on the brand new investment, Gautam Chopra, Co-Founder and CEO, BeatO said, “With our virtual-first solution, It is properly located to put the brand new requirements of ways care may be brought withinside the destiny to hundreds of thousands of Indians. We are thrilled to have an awesome set of companions becoming a member of us on the adventure who deeply resonate with our imaginative and prescient and convey stable competencies to assist us attain our goal.”
Tejasvi Ravi, who leads healthcare investments at Lightrock India added, “BeatO is on a formidable undertaking to re-layout how diabetes is cared for in India. They are a world-elegance crew which have confirmed the cap potential to supply consistent, terrific and empathetic care ensuing in scientific effects which are outstanding.”
The sparkling budget may be utilized to make bigger BeatO`s diabetes care applications pan-India, spend money on strengthening their management crew and to similarly spend money on it’s product and technology. It will even retain the proof base for its care applications, placing the same old care globally for diabetes. BeatO targets to serve over 10 million sufferers via means of 2025, turning into India’s biggest Diabetes Care Company.
Speaking at the funding, Ravi Iyer, Senior Vice President and Head – Corporate Development, at Flipkart, said, “Through this funding in BeatO, Flipkart ventures is devoted to helping a commercial enterprise that is constructing next-technology improvements and evolving the virtual fitness ecosystem. BeatO, with its holistic, differentiated and cheap virtual care solution, is properly located to cope with the growing diabetes epidemic in India.”
The Company’s present marquee traders encompass Orios Venture Partners, Leo Capital, W Health Ventures, Blume Ventures and others.
Follow Startup Story
Related Posts
